# US 2018/0022831 A1 · Nanoparticle-protein complex for intracellular protein delivery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0022831 A1
- Document ID: US20180022831A1
- Status: Published application
- Kind: A1
- Application number: 15/547,404
- Filed: 2016-01-29
- Published: 2018-01-25
- Earliest claimed: 2015-01-29
- Assignees: University of Massachusetts
- Applicants: University of Massachusetts
- Inventors: Vincent M. Rotello; Rubul Mout
- Web page: https://patentgrep.com/patent/US20180022831A1

## CPC

- C07K 17/14: Peptides being immobilised on, or in, an inorganic carrier
- A61K 47/6923: {the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb}
- C12N 9/1241: {Nucleotidyltransferases (2.7.7)}
- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12N 9/222: {Clustered regularly interspaced short palindromic repeats [CRISPR]-associated [CAS] enzymes}
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12N 9/6467: {Granzymes, e.g. granzyme A (3.4.21.78); granzyme B (3.4.21.79)}
- C12N 9/96: Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 15/907: {in mammalian cells}
- C12Y 304/21078: Granzyme A (3.4.21.78)
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

Various embodiments disclosed relate to a nanoparticle-protein complex for intracellular protein delivery. In various embodiments, the present invention provides a nanoparticle-protein complex including a nanoparticle including an amine-containing ligand. The nanoparticle-protein complex also includes a protein comprising a carboxylic acid-containing tag.

## Claims

### Claim 1

A nanoparticle-protein complex comprising:
a nanoparticle comprising an amine-containing ligand; and
a protein comprising a carboxylic acid-containing tag.

### Claim 2 (depends on 1)

The nanoparticle-protein complex of claim 1, wherein the nanoparticle-protein complex has about 1 to about 10,000 of the nanoparticles.

### Claim 3 (depends on 1)

The nanoparticle-protein complex of claim 1, wherein the nanoparticle-protein complex has about 1 to about 10,000 molecules of the protein.

### Claim 4 (depends on 1)

The nanoparticle-protein complex of claim 1, wherein the nanoparticle comprises at least one of gold, iron oxide, cobalt ferrite, and silica.

### Claim 5 (depends on 1)

The nanoparticle-protein complex of claim 1, wherein the amine-containing ligand is a guanidine-containing ligand or an arginine-containing ligand.

### Claim 6 (depends on 1)

The nanoparticle-protein complex of claim 1, wherein the amine-containing ligand has the structure:
or a salt thereof, wherein m is 0 to 1,000 and n is 0 to 1,000.

### Claim 7 (depends on 1)

The nanoparticle-protein complex of claim 1, wherein the amine-containing ligand has the structure:

### Claim 8 (depends on 1)

The nanoparticle-protein complex of claim 1, wherein the protein is chosen from GFP, Granzyme A, mCherry, Cre recombinase, Cas9, Histone 2A, and combinations thereof.

### Claim 9 (depends on 1)

The nanoparticle-protein complex of claim 1, wherein the carboxylic acid-containing tag comprises a glutamic acid tag or a poly(glutamic acid) tag.

### Claim 10 (depends on 1)

The nanoparticle-protein complex of claim 1, wherein the carboxylic acid-containing tag has the structure:
or a salt thereof,
or,
or a salt thereof,
wherein n is about 1 to about 10,000.

### Claim 11 (depends on 10)

The nanoparticle-protein complex of claim 10, wherein n is about 5 to about 20.

### Claim 12 (depends on 1)

The nanoparticle-protein complex of claim 1, further comprising a nucleic acid material.

### Claim 13 (depends on 12)

The nanoparticle-protein complex of claim 12, wherein the nucleic acid material comprises at least one of mRNA (messenger RNA), rRNA (ribosomal RNA), 7SL RNA or SRP RNA (signal recognition particle RNA), tRNA (transfer RNA), tmRNA (transfer-messenger RNA), snRNA (small nuclear RNA), snoRNA (small nucleolar RNA), SmY (SmY RNA), scaRNA (small Cajal body-specific RNA), gRNA (guide RNA), catalytic RNA, RNase P (ribonuclease P), RNase MRP (ribonuclease MRP), oligonucleotide RNA, Y RNA, TERC (telomerase RNA component), SL RNA (spliced leader RNA), aRNA or asRNA (antisense RNA), cis-NAT (cis-natural antisense transcript), crRNA (CRISPR RNA), IncRNA (long noncoding RNA), miRNA (microRNA), piRNA (piwi-interacting RNA), siRNA (small interfering RNA), tasiRNA (trans-acting siRNA), rasiRNA (repeat associated siRNA), and 7SK (7SK RNA).

### Claim 14 (depends on 12)

The nanoparticle-protein complex of claim 12, wherein the nucleic acid material is gRNA (guide RNA).

### Claim 15 (depends on 1)

The nanoparticle-protein complex of claim 1, wherein the protein further comprises an organelle-localization signal.

### Claim 16 (depends on 1)

The nanoparticle-protein complex of claim 1, further comprising an antibody comprising a carboxylic acid-containing tag.

### Claim 17 (depends on 1)

A method of using the nanoparticle-protein complex of claim 1 to deliver the protein to a cell, comprising contacting the nanoparticle-protein complex with one or more cells.

### Claim 18 (depends on 1)

A method of forming the nanoparticle-protein complex of claim 1, the method comprising:
combining the nanoparticle comprising an amine-containing ligand with the protein comprising a carboxylic acid-containing tag to form a self-assembled nanoparticle-protein complex that is the nanoparticle-protein complex of claim 1.

### Claim 19

A nanoparticle-protein complex comprising:
a gold nanoparticle comprising an amine-containing ligand having the structure:
or a salt thereof, wherein m is 0 to 1,000 and n is 0 to 1,000; and
a protein comprising a carboxylic acid-containing tag having the structure:
or a salt thereof,
or,
or a salt thereof,
wherein n is about 1 to about 10,000, wherein the protein is chosen from GFP, Granzyme A, mCherry, Cre recombinase, Cas9, Histone 2A, and combinations thereof;
wherein the nanoparticle-protein complex has a largest dimension of about 50 to about 999 nm, the gold nanoparticle has a largest dimension of about 1 nm to about 50 nm, in solution the protein has a largest dimension of about 0.5 nm to about 50 nm, the gold nanoparticle has about 1 to about 10,000 of the amine-containing ligands, the nanoparticle-protein complex has about 1 to about 10,000 of the gold nanoparticles, and the nanoparticle-protein complex has about 1 to about 10,000 molecules of the protein.

### Claim 20

A nanoparticle-protein complex comprising:
a gold nanoparticle comprising an amine-containing ligand having the structure:
or a salt thereof, wherein m is 0 to 1,000 and n is 0 to 1,000;
a protein comprising a carboxylic acid-containing tag having the structure:
or a salt thereof,
or,
or a salt thereof,
wherein n is about 1 to about 10,000, wherein the protein is chosen from GFP, Granzyme A, mCherry, Cre recombinase, Cas9, Histone 2A, and combinations thereof; and
a nucleic acid material that is gRNA;
wherein the nanoparticle-protein complex has a largest dimension of about 50 to about 999 nm, the gold nanoparticle has a largest dimension of about 1 nm to about 50 nm, in solution the protein has a largest dimension of about 0.5 nm to about 50 nm, the gold nanoparticle has about 1 to about 10,000 of the amine-containing ligands, the nanoparticle-protein complex has about 1 to about 10,000 of the gold nanoparticles, the nanoparticle-protein complex has about 1 to about 10,000 molecules of the protein, and the nanoparticle-protein complex has about 1 to about 10,000 molecules of the nucleic acid material.
